Team Led by President Ono Wins $3.7 Million NSF Grant
A $3,749,336 grant from the National Science Foundations ADVANCE Institutional Transformation Program will bolster the University of Cincinnatis efforts to increase the participation and advancement of women faculty, including women of color, in science, technology, engineering and math (STEM) disciplines. The principal investigator for the grant is
Interim President Santa J. Ono
. His co-principal investigators include Melanie T. Cushion (Program Director) of the College of Medicine, Rachel Kallen and Stacie-Furst Holloway (Associate Program Directors) of the McMicken College of Arts and Sciences, Steve Howe, also of the College of Arts and Sciences, and Urmila Ghia of the College of Engineering and Applied Sciences.
The five-year grant, titled Leadership, Empowerment and Advancement of Women Stem Faculty (LEAF), will make UC a model institution for women STEM scientists.
The STEM disciplines are absolutely essential to the economic development of our region and nation. Already, one-third of our STEM faculty at UC are over the age of 60, said President Ono. If we want to remain competitive in a global economy, we must do a better job of recruiting and retaining women into these fields, and UC is ready and willing to do its part, with the help of the National Science Foundation.
LEAF will work to transform the culture of the universitys STEM departments to promote equity and professional success for women scientists. Its initiatives include:
- Enhancement of the pipeline for women faculty in STEM fields by broadening recruitment, improving hiring, increasing retention and promoting advancement.
- Transforming the climate for STEM faculty by creating social and collaborative mentoring networks to promote intellectual progress, equity and an inclusive culture.
- Creating interdependence by enabling sustainable dynamic institutional practice and policy through the establishment of an Accountability and Advocacy Council, which will assess progress and success as strategies are implemented.
- Conducting research on social networks and discourse regarding STEM.
- Addressing the unique needs of UCs STEM faculty who are women of color.
Plans for programming include a series of professional development workshops for women in STEM fields at different career stages, learning communities for informal and formal mentoring of female STEM scientists, and seed grants to support research, professional development and collaboration.
In addition, there will be programming targeted to deans, department heads and search committee members to provide training in best practices for hiring, promotion and tenure, as well as mentoring and coaching of administrators to facilitate accountability, transparency and inclusiveness.
Resulting policies and procedures are expected to transform UC as a go-to institution for women STEM faculty and enhance the research, teaching and community missions of the University for all faculty.
Additional Contacts
Katie Pence | Director | Media Relations + Content
katie.pence@uc.edu | 513-558-4561
Related Stories
ChemoID test leads to better outcomes in platinum-resistant...
April 7, 2025
MSN and MSN UK highlighted results from a new Phase 3 trial published in the journal npj Precision Oncology that found a cancer stem cell test can accurately choose more effective treatments and lead to improved outcomes for patients with platinum-resistant ovarian cancer.
OTR mural celebrates UC alumni success
April 4, 2025
The UC Alumni Association, UCAA, will mark its annual Alumni Celebration during its upcoming Alumni Week, April 7-13, with a community art project commemorating this year’s slate of alumni honorees receiving the organization’s top awards.
Study: Platform-predicted treatments improve outcomes for...
April 4, 2025
Results from a new Phase 3 trial published in the journal npj Precision Oncology found that an assay that includes an assessment of cancer stem cell sensitivity to chemotherapy can accurately decide more effective treatments and lead to increased outcomes for patients with platinum-resistant ovarian cancer.